Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 3/2009

01-03-2009 | Brief Report

Rapid detection of bla KPC -positive Klebsiella pneumoniae in a clinical setting

Authors: T. Kotlovsky, R. Shalginov, L. Austin, H. Sprecher

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 3/2009

Login to get access

Excerpt

Early detection and institution of adequate antibiotic treatment have been shown to be of major importance in determining the outcome of patients with systemic infections [1]. Klebsiella pneumoniae (KP) ranks second in the list of causes of Gram-negative sepsis at our medical center. Forty-five percent of the isolates display an extended spectrum β-lactamase producer (ESBL) phenotype, necessitating administration of broad spectrum antibiotics. Starting in January 2006, the prevalence of carbapenem-resistant (CR) KP isolates increased significantly. Similar trends have been recorded worldwide [2]. Molecular diagnosis has recently been recognized as an important diagnostic tool for the rapid detection and identification of pathogenic organisms in clinical samples, and is also increasingly utilized to detect antimicrobial-resistance genes in various micro-organisms [3]. The aim of the present study was to establish a rapid and reliable PCR-based assay aimed at detecting CR-KP DNA in order to reduce the interval between specimen sampling and initiation of pathogen-targeted antibiotic treatment, and thereby to improve the management of KP-CR outbreaks. …
Literature
1.
go back to reference Harbarth S, Garbino J, Pugin J et al (2003) Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 115:529–535PubMedCrossRef Harbarth S, Garbino J, Pugin J et al (2003) Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 115:529–535PubMedCrossRef
2.
go back to reference Woodford N, Tierno PM Jr, Young K et al (2004) Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A ß-lactamase, KPC-3, in a New York medical center. Antimicrob Agents Chemother 48:4793–4799PubMedCrossRef Woodford N, Tierno PM Jr, Young K et al (2004) Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A ß-lactamase, KPC-3, in a New York medical center. Antimicrob Agents Chemother 48:4793–4799PubMedCrossRef
3.
go back to reference Tenover FC (2007) Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond. Clin Infect Dis 44:418–423PubMedCrossRef Tenover FC (2007) Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond. Clin Infect Dis 44:418–423PubMedCrossRef
4.
go back to reference Clinical and Laboratory Standards Institute (2006) Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA Clinical and Laboratory Standards Institute (2006) Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA
5.
go back to reference Neuberger A, Oren I, Sprecher H (2008) Clinical impact of a PCR assay for rapid identification of Klebsiella pneumoniae in blood cultures. J Clin Microbiol 46:377–379PubMedCrossRef Neuberger A, Oren I, Sprecher H (2008) Clinical impact of a PCR assay for rapid identification of Klebsiella pneumoniae in blood cultures. J Clin Microbiol 46:377–379PubMedCrossRef
6.
go back to reference Yigit H, Queenan AM, Anderson GJ et al (2001) Novel carbapenemase-hydrolysing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151–1161PubMedCrossRef Yigit H, Queenan AM, Anderson GJ et al (2001) Novel carbapenemase-hydrolysing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151–1161PubMedCrossRef
7.
go back to reference Smith Moland E, Hanson ND, Herrera VL et al (2003) Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae. J Antimicrob Chemother 51:711–714PubMedCrossRef Smith Moland E, Hanson ND, Herrera VL et al (2003) Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae. J Antimicrob Chemother 51:711–714PubMedCrossRef
8.
go back to reference Landman D, Salvani JK, Bratu S et al (2005) Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures. J Clin Microbiol 43:5639–5641PubMedCrossRef Landman D, Salvani JK, Bratu S et al (2005) Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures. J Clin Microbiol 43:5639–5641PubMedCrossRef
9.
go back to reference Tenover FC, Kalsi RK, Williams PP et al (2006) Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis 12:1209–1213PubMed Tenover FC, Kalsi RK, Williams PP et al (2006) Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis 12:1209–1213PubMed
10.
go back to reference Woodford N, Sundsfjord A (2005) Molecular detection of antibiotic resistance: when and where? J Antimicrob Chemother 56:259–261PubMedCrossRef Woodford N, Sundsfjord A (2005) Molecular detection of antibiotic resistance: when and where? J Antimicrob Chemother 56:259–261PubMedCrossRef
Metadata
Title
Rapid detection of bla KPC -positive Klebsiella pneumoniae in a clinical setting
Authors
T. Kotlovsky
R. Shalginov
L. Austin
H. Sprecher
Publication date
01-03-2009
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 3/2009
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-008-0615-2

Other articles of this Issue 3/2009

European Journal of Clinical Microbiology & Infectious Diseases 3/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.